Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Brain Cancer treatment details. Chemotherapy. Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

Survival: 7.6 months
Toxicity Grade: 4
Treatments: Chemotherapy
Country: Switzerland
City/State/Province: Lausanne
Hospital: Centre Hospitalier Universitaire Vaudois
Journal: Link
Date: 2/2011

This study involved 37 glioblastoma patients who had previously been treated and had recurrence or progression of their disease. The median patient age was 57 years and 76% were male.

Patients were treated with a chemotherapy agent called sagopilone, also known as ZK-EPO or ZK-219477.

The maximum toxicity level reported was of grade 4, consisting of one case of peripheral neuropathy. Also reported were 3 cases each of grade 3 fatigue and neutropenia.

The reported median overall survival was 7.6 months.

This study was supported by Bayer Schering Pharma, makers of sagopilone.

Correspondence: Dr. Roger Stupp; email:

E-mail to a Friend Email Physician More Information